People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Personalis, Inc. | — | Biotechnology | Series B | $68.9M | $485.2M | 2017 |
| PrimeraDx, Inc. | — | Biotechnology | Series B | $20.9M | $784.3M | 2009 |
Vincent Miles at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Vincent Miles on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nina Kjellson | 1 | 11 |
| Jonathan MacQuitty | 1 | 7 |
| Chris Schaepe | 1 | 6 |
| JON FEIBER | 1 | 5 |
| Andrew Chung | 1 | 4 |
| Ronald Lennox | 1 | 3 |
| Patrick Balthrop | 1 | 3 |
| Ken Ludlum | 1 | 3 |
| Martin Verhoef | 1 | 3 |
| Michael Bigham | 1 | 3 |
| Sue Siegel | 1 | 2 |
| John West | 1 | 2 |
| Norhalim Yunus | 1 | 2 |
| Laurence McCarthy | 1 | 1 |
| Robert Rosenthal | 1 | 1 |
| Carol Tillis | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.